Clinical Trial Update: Neoadjuvant Gemcitabine and Fractionated, Weekly Cisplatin For Muscle Invasive Bladder Cancer and Patients Not Candidates For High Dose Cisplatin [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant gemcitabine plus weekly cisplatin for muscle-invasive bladder cancer (including patients not candidates for high-dose cisplatin) was termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Muscle-invasive Bladder Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Platinol (cisplatin)

Snippet

Sponsor: Brown University | Conditions: Invasive Bladder Cancer, Bladder Cancer | Phase 2 | Status: TERMINATED | Results posted: 2016-03-25